Menu
ChAImeleon aims to set up a structured repository for health imaging data to be openly reused in AI experimentation for cancer management, with the creation of four datalakes for four cancers: lung, breast, colorectal, prostate.
As a contributor to the winning consortium, our unique expertise —combining scientific sensitivity, maturity on technical platforms, a legal and regulatory knowledge and a collaborative spirit— allows us to cover legal, interoperability, platform architecture and internal consulting for data integration.
Karine Seymour, Medexprim founder and Chief innovation officer, is the designated consortium technical coordinator.
Grant agreeement ID: 952172
- Clinical partners and external collaborators will populate the repository with multimodality imaging and related clinical data for historic and newly diagnosed cancer patients.
- AI-powered pipelines will automate data de-identification, curation, annotation, integrity securing and image harmonization, enabling reproducibility of Radiomics with large image datasets.
- Analytical data engine will interpret, extract and exploit the right information stored at the Repository.
- Early in-silico validation of selected AI tools will be conducted in observational clinical studies coordinated by leading experts: Gustave Roussy (lung), San Donato (breast), Sapienza (colorectal), La Fe (prostate).
« I am very proud and excited to take part to this ambitious EU project. It follows the Primage project in which we were already involved.
It’s a big challenge, but it’s 100% in line with Medexprim’s core mission and expertise. We were waiting for such a program to get recognition from our peers and to establish our notoriety. Now, we have to deliver ! »
